These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21727276)

  • 21. Prophylactic indomethacin worsens short-term respiratory outcomes in extremely low-birth-weight infants.
    Mondal T; Chaudhuri D; Li B; Shivananda S; Dutta S
    Am J Perinatol; 2014 Jan; 31(1):61-7. PubMed ID: 23456903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.
    Fowlie PW; Davis PG
    Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F464-6. PubMed ID: 14602691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.
    Yang CZ; Lee J
    World J Pediatr; 2008 May; 4(2):91-6. PubMed ID: 18661761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates.
    Doni D; Paterlini G; Locatelli A; Arnoldi S; Magri MC; Bernasconi D; Valsecchi MG; Tagliabue PE
    J Matern Fetal Neonatal Med; 2020 Feb; 33(4):645-650. PubMed ID: 29986620
    [No Abstract]   [Full Text] [Related]  

  • 28. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes following indomethacin prophylaxis in extremely preterm infants in an all-referral NICU.
    Nelin TD; Pena E; Giacomazzi T; Lee S; Logan JW; Moallem M; Bapat R; Shepherd EG; Nelin LD
    J Perinatol; 2017 Aug; 37(8):932-937. PubMed ID: 28617424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms.
    Kabra NS; Schmidt B; Roberts RS; Doyle LW; Papile L; Fanaroff A;
    J Pediatr; 2007 Mar; 150(3):229-34, 234.e1. PubMed ID: 17307535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early prediction of poor outcome in extremely low birth weight infants by classification tree analysis.
    Ambalavanan N; Baibergenova A; Carlo WA; Saigal S; Schmidt B; Thorpe KE;
    J Pediatr; 2006 Apr; 148(4):438-444. PubMed ID: 16647401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.
    Fowlie PW; Davis PG; McGuire W
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000174. PubMed ID: 20614421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.
    Mirza H; Laptook AR; Oh W; Vohr BR; Stoll BJ; Kandefer S; Stonestreet BS;
    Arch Dis Child Fetal Neonatal Ed; 2016 Sep; 101(5):F418-22. PubMed ID: 26733540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants.
    Ment LR; Duncan CC; Ehrenkranz RA; Kleinman CS; Pitt BR; Taylor KJ; Scott DT; Stewart WB; Gettner P
    J Pediatr; 1985 Dec; 107(6):937-43. PubMed ID: 3906073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indomethacin prophylaxis revisited: changing practice and supportive evidence.
    AlFaleh K
    Acta Paediatr; 2011 May; 100(5):641-6. PubMed ID: 21284720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
    Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
    JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.